Pepticom Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Pepticom Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10985
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pepticom Ltd (Pepticom) is a drug discovery and development company focused on novel peptide drug candidates. The company’s artificial intelligence platform for peptide design models based on the target’s solved crystal structure of the target protein. Its products includes copaxone, used for the treatment of multiple sclerosis; victoza, a long-acting glucagon-like peptide-1 receptor agonist used for treatment of type 2 diabetes; byetta, and byureron. Pepticom offers software design platform models such as linear petide design, helica peptide design, cyclic petide design, and D-amino acids peptide design, among others. The company’s products are used in the therapeutic areas of oncology, metabolic and cardiovascular disease to infectious diseases, gastroenterology, allergies and pain. The company works in collaboration with other research universities and organizations for new drug discovery opportunities. Pepticom is headquartered in Jerusalem, Israel.

Pepticom Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pepticom Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pepticom Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pepticom Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pepticom Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Pepticom Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Pepticom Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Pepticom Raises Funds through Seed Financing 10
Partnerships 11
Pepticom and Hadasit Medical Research Services Enter into Agreement 11
Pepticom Enters into Co-Development Agreement with Tufts Medical Center 12
Pepticom Enters into Co-Development Agreement with Fraunhofer Institute 13
Pepticom Enters into Co-Development Agreement with TargetEx 14
Pepticom Enters into Co-Development Agreement with EMC Microcollections and University of Stuttgart 15
Pepticom Ltd – Key Competitors 16
Pepticom Ltd – Key Employees 17
Pepticom Ltd – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
Jun 30, 2018: Pepticom appoints Pierre Riviere to its Scientific Advisory Board 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Pepticom Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Pepticom Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pepticom Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pepticom Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pepticom Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Pepticom Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Pepticom Raises Funds through Seed Financing 10
Pepticom and Hadasit Medical Research Services Enter into Agreement 11
Pepticom Enters into Co-Development Agreement with Tufts Medical Center 12
Pepticom Enters into Co-Development Agreement with Fraunhofer Institute 13
Pepticom Enters into Co-Development Agreement with TargetEx 14
Pepticom Enters into Co-Development Agreement with EMC Microcollections and University of Stuttgart 15
Pepticom Ltd, Key Competitors 16
Pepticom Ltd, Key Employees 17

List of Figures
Pepticom Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Pepticom Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Pepticom Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Pepticom Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Pepticom Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pepticom Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Pepticom Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pepticom Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Pepticom Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cinemark Holdings Inc (CNK):企業の財務・戦略的SWOT分析
    Cinemark Holdings Inc (CNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Sri Ayudhya Capital Public Company Limited:企業の戦略・SWOT・財務分析
    Sri Ayudhya Capital Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Sri Ayudhya Capital Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Cydan Development Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Cydan Development Inc (Cydan) is an orphan drug accelerator dedicated to advancing therapies for rare genetic diseases. The company identifies assets with biology and proof-of-concept data in vivo models from academic circles, industry, and other sources. It offers various technology platfor …
  • Streamline Health Solutions Inc (STRM):企業の財務・戦略的SWOT分析
    Summary Streamline Health Solutions Inc (Streamline Health) is a provider of in revenue cycle management. The company offers patient engagement and SaaS-based solutions. Its portfolio of services includes Health Information Management (HIM), patient care, patient engagement, coding and Clinical Docu …
  • PacifiCorp:発電所・企業SWOT分析
    PacifiCorp - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executi …
  • Taconic Biosciences Inc-医療機器分野:企業M&A・提携分析
    Summary Taconic Biosciences Inc (Taconic), formerly Taconic Farms Inc is a research model provider that offers animal health models and laboratory services. The company’s products include taconic transgenic models, emerging models, knockout repository, GEM collection, traditional models, diet induce …
  • Water Intelligence PLC (WATR):企業の財務・戦略的SWOT分析
    Summary Water Intelligence plc (Water Intelligence) formerly Qonnectis Plc, is a clean technology company that offers environmental and technology services. The company offers services such as finding, detecting, and remediating water leaks services. It monitors and protects water infrastructure and …
  • Callaway Golf Co (ELY):企業の財務・戦略的SWOT分析
    Callaway Golf Co (ELY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Flowonix Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Flowonix Medical Inc (Flowonix), formerly Medasys Inc is a medical device company that designs and manufactures implantable drug pump to deliver therapeutic drugs into the spine to relieve chronic disorders. The company's products comprise prometra pump, catheter, and accessories and program …
  • Daihachi Chemical Industry Co Ltd:企業の戦略的SWOT分析
    Daihachi Chemical Industry Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • PT Pembangkitan Jawa-Bali:企業の戦略的SWOT分析
    PT Pembangkitan Jawa-Bali - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Ladbrokes plc:戦略・SWOT・企業財務分析
    Ladbrokes plc - Strategy, SWOT and Corporate Finance Report Summary Ladbrokes plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • DSW Inc.:企業の戦略・SWOT・財務情報
    DSW Inc. - Strategy, SWOT and Corporate Finance Report Summary DSW Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Lay Hong Berhad (LAYHONG):企業の財務・戦略的SWOT分析
    Lay Hong Berhad (LAYHONG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Centre de Regulacio Genomica-製薬・医療分野:企業M&A・提携分析
    Summary Centre de Regulacio Genomica (CRG) is a biomedical institute that provides research services. The institute provides research programs such as bioinformatics and genomics, cell and developmental biology, gene regulation, stem cells and cancer and systems biology, among others. It offers faci …
  • Linde AG (LIN)-製薬・医療分野:企業M&A・提携分析
    Summary Linde AG (Linde) is a provider of industrial gases and engineering services. The company specializes in the planning, procurement, construction and operation of gas production and processing plants. Linde offers a wide range of compressed and liquefied gases, and chemicals, and offers facili …
  • Machavert Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Machavert Pharmaceuticals LLC (Machavert Pharmaceuticals) is a bio-pharmaceutical company which develops novel non-toxic medicines for the treatment of cancer and autoimmune diseases. Its lead drug candidate MP1000, a nanoparticulate liposomal phospholipid immune-modulating agent exhibits an …
  • Zimmer Biomet Holdings Inc (ZBH)-製薬・医療分野:企業M&A・提携分析
    Summary Zimmer Biomet Holdings Inc (Zimmer Biomet) is a medical device company with focus on musculoskeletal healthcare. It carries out the design, development, manufacture, and marketing of reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, cr …
  • TES Aviation Group:企業の戦略・SWOT・財務情報
    TES Aviation Group - Strategy, SWOT and Corporate Finance Report Summary TES Aviation Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Inform Genomics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Inform Genomics Inc (Inform Genomics) manufactures and markets genomic-based personalized medicine products for cancer and supportive care. The company’s onpart is a medicinal product, which is used for the treatment of decisions in patients, who receive chemotherapy for colorectal, breast, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆